Skip to main content

A Double Blind, Randomized, Controlled Pharmacokinetic and Pharmacodynamics Trial of Ambrisentan After Fontan Surgery

Publication ,  Conference
Hill, KD; Maharaj, A; Thompson, E; Li, JS; Pearson, E; Hornik, C
Published in: CIRCULATION
2018

Duke Scholars

Published In

CIRCULATION

EISSN

1524-4539

ISSN

0009-7322

Publication Date

2018

Volume

138

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hill, K. D., Maharaj, A., Thompson, E., Li, J. S., Pearson, E., & Hornik, C. (2018). A Double Blind, Randomized, Controlled Pharmacokinetic and Pharmacodynamics Trial of Ambrisentan After Fontan Surgery. In CIRCULATION (Vol. 138).
Hill, Kevin D., Anil Maharaj, Elizabeth Thompson, Jennifer S. Li, Elliott Pearson, and Christoph Hornik. “A Double Blind, Randomized, Controlled Pharmacokinetic and Pharmacodynamics Trial of Ambrisentan After Fontan Surgery.” In CIRCULATION, Vol. 138, 2018.
Hill KD, Maharaj A, Thompson E, Li JS, Pearson E, Hornik C. A Double Blind, Randomized, Controlled Pharmacokinetic and Pharmacodynamics Trial of Ambrisentan After Fontan Surgery. In: CIRCULATION. 2018.
Hill KD, Maharaj A, Thompson E, Li JS, Pearson E, Hornik C. A Double Blind, Randomized, Controlled Pharmacokinetic and Pharmacodynamics Trial of Ambrisentan After Fontan Surgery. CIRCULATION. 2018.

Published In

CIRCULATION

EISSN

1524-4539

ISSN

0009-7322

Publication Date

2018

Volume

138

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology